Page last updated: 2024-12-11
alanyllactate
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
D-alanyl-(R)-lactic acid : A D-alanyl ester that results from the formal condensation of the alcoholic hydroxy group of (2R)-lactic acid with the carboxylic acid group of D-alanine. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 5487001 |
CHEBI ID | 61163 |
SCHEMBL ID | 12190137 |
MeSH ID | M0211318 |
Synonyms (23)
Synonym |
---|
(r)-alanyl-(r)-lactic acid |
136577-07-6 |
(r)-2-((r)-2-aminopropanoyloxy)propanoic acid |
d-alanyl-(r)-lactate |
CHEBI:61163 |
(2r)-2-(d-alanyloxy)propionic acid |
(r)-2-((r)-2-aminopropanoyloxy)propionic acid |
(2r)-2-(d-alanyloxy)propanoic acid |
d-alanyl-d-lactic acid |
d-alanyl-(r)-lactic acid |
alanyllactate |
d-alanyl-d-lactate |
(2r)-2-[(2r)-2-aminopropanoyl]oxypropanoic acid |
(r)-2-[(r)-2-aminopropanoyloxy]propanoic acid |
C19694 |
SCHEMBL12190137 |
d-alanine, 1-carboxyethyl ester, (r)- |
alanyl-lactate |
DTXSID90159839 |
d-alanine, (1r)-1-carboxyethyl ester (9ci) |
Q27130856 |
(2r)-2-{[(2r)-2-aminopropanoyl]oxy}propanoic acid |
EN300-7712981 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Drug Classes (3)
Class | Description |
---|---|
depsipeptide | A natural or synthetic compound having a sequence of amino and hydroxy carboxylic acid residues (usually alpha-amino and alpha-hydroxy acids), commonly but not necessarily regularly alternating. |
D-alanyl ester | Any alpha-amino acid ester that results from the formal condensation of the carboxylic acid group of D-alanine with an alcohol. |
zwitterion | A neutral compound having formal unit electrical charges of opposite sign on non-adjacent atoms. Sometimes referred to as inner salts, dipolar ions (a misnomer). |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (10)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (40.00) | 18.2507 |
2000's | 3 (30.00) | 29.6817 |
2010's | 3 (30.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.07
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.07) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 10 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |